Iovance Biotherapeutics
IOVA
IOVA
295 hedge funds and large institutions have $1.86B invested in Iovance Biotherapeutics in 2024 Q2 according to their latest regulatory filings, with 68 funds opening new positions, 114 increasing their positions, 80 reducing their positions, and 41 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
5.33% more ownership
Funds ownership: 77.77% → 83.1% (+5.3%)
38% less funds holding in top 10
Funds holding in top 10: 8 → 5 (-3)
42% less capital invested
Capital invested by funds: $3.22B → $1.86B (-$1.35B)
Holders
295
Holding in Top 10
5
Calls
$25.3M
Puts
$18.5M
Top Buyers
| 1 | +$71.4M | |
| 2 | +$43.3M | |
| 3 | +$35.8M | |
| 4 |
LFCM
Long Focus Capital Management
San Juan,
Puerto Rico
|
+$29.3M |
| 5 |
State Street
Boston,
Massachusetts
|
+$23.8M |
Top Sellers
| 1 | -$25M | |
| 2 | -$22M | |
| 3 | -$19.1M | |
| 4 |
D.E. Shaw & Co
New York
|
-$18.2M |
| 5 |
Millennium Management
New York
|
-$15.5M |